PNG version of QUB Shield - Red



Morgan E, Drummond FJ, Coyle C, Sharp L, Gavin AT. Physical after-effects in men undergoing prostate biopsy in routine clinical practice: Results from the PiCTure study. Urol Oncol. 2017 Oct;35(10):604.e11-604.e16.

Keinan-Boker L, Silverman BG, Walsh PM, Gavin AT, Hayes C. Time Trends in the Incidence and Mortality of Ovarian Cancer in Ireland, Northern Ireland, and Israel, 1994-2013. Int J Gynecol Cancer. 2017 Oct;27(8):1628-1636.

G. Gatta a, R. Peris-Bonet, O. Visser, C. Stiller, R. Marcos-Gragera, M.-J. Sa´nchez, B. Lacour, P. Kaatsch, F. Berrino, S. Rutkowsky, L. Botta, and the EUROCARE-5 Working Group *(includes Dr Anna Gavin). Geographical variability in survival of European children with central nervous system tumours, Accepted European Journal of Cancer 16 May 2017, DOI:/10.1016/j.ejca.2017.05.028. 

Donnelly CB, Wotherspoon AC, Morris M, Wilson RH, Chen JJ, Cairnduff V, Morgan E, Devlin A, Gavin AT. A population-level investigation of cancer clinical trials participation in a UK region.  Accepted by European Journal of Public Health May 2017. DOI: 10.1097/CEJ.0000000000000373. Implications of Research for Services download

Conan Donnelly, Samantha Quaife, Lindsay Forbes, Jackie Boylan, Carol Tishelman, Anna Gavin. Do perceived barriers to clinical presentation affect anticipated time to presenting with cancer symptoms: an ICBP study. Accepted by European Journal of Pub Health June 2017. Implications of Research for Services download